Physician profile
Dane E Sobek
NPI 1043257306
$8,197.44
in general payments reported to CMS, 2019-2025
8 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,959 · 2020: $18.90 · 2021: $39.55 · 2022: $195 · 2023: $2,384 · 2024: $2,222 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,581 · Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,580.65 |
| Food and Beverage | $1,404.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,072.73 | 2019-2024 | Aveir, Assurity |
| Medtronic, INC. | $2,458.98 | 2021-2025 | Micra, Selectsecure, Onyx Frontier |
| Medtronic Vascular, INC. | $1,181.11 | 2019-2020 | |
| Abiomed | $278.31 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $150.95 | 2025 | Gore Cardioform Asd Occluder |
| Argon Medical Devices, INC. | $19.97 | 2022 | |
| Biosense Webster, INC. | $18.14 | 2025 | Soundstar |
| Impulse Dynamics (USA) INC. | $17.25 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Sobek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.